Safety and Efficacy of RPH-104 Used to Prevent Recurrent Fever Attacks in Adult Patients With Colchicine Resistant or Colchicine Intolerant Familial Mediterranean Fever — Stella
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
(8 sites) Armenia
Center of Medical Genetics and Primary Health Care LLC, Yerevan Russia
FSBEI HE First Moscow State Medical University named after I.M. Sechenov, Moscow Moscow Multidisciplinary Scientific and Clinical Center named after S.P. Botkin, Moscow Medical Technologies Ltd., Saint Petersburg Turkey (Türkiye)
Hacettepe University Faculty of Medicine, Ankara Istanbul University Istanbul Faculty of Medicine, Istanbul Istanbul University Cerrahpasa Faculty of Medicine, Istanbul
Key details Sponsor
R-Pharm International, LLC
Collaborators
Atlant Clinical LLC, Unimed Laboratories
Enrollment target
~60 participants
Primary completion
December 2028
Last updated December 2024